The FDA approved VIZZ, the first pharmacological treatment for presbyopia, offering once-daily near-vision improvement with a pupil-selective miotic and up to 10 hours of effect.
The FDA’s approval of injectable lenacapavir marks a breakthrough for global HIV prevention. Discover how this twice-yearly shot could transform access and outcomes.
MoneyOval is a global media company delivering insights at the intersection of finance, business, technology, and innovation.
From boardroom decisions to blockchain trends, MoneyOval provides clarity to the forces driving today’s economic landscape.